Sorted By:


Australia’s opportunity to lead the TPP forward

PhRMA  |  Blog Post

But innovative drug-makers are not going to invest in Australia if their discoveries, their IP, are better protected elsewhere; they may not even apply to sell their products there.

PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy

PhRMA  |  Press Release

PhRMA companies are leading the way in the search for new cures.

Director – Public Affairs

PhRMA  |  PhRMA Career

Equal Opportunity Employer PhRMA provides equal employment opportunities to all applicants without regard to race, color, religion, national origin, sex, age, marital status, personal appearance, sexual orientation, gender identity or expression, family responsibilities, genetic information, disability, matriculation, political affiliation or veteran status in accordance with applicable federal, state and local laws governing non-discrimination in employment.

Burden on Patients: Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines

PhRMA  |  Blog Post

For more on the current state-of-affairs for mental health innovation and what we need to do to ensure patients have access to the best possible treatment options, we encourage you to read about our Mental Health Capitol Hill briefing held last week.

PPA Celebrates Fourth Anniversary Has Helped More Than 5.7 Million Uninsured Patients

PhRMA  |  Press Release

It only takes 10 to 15 minutes to find out if someone may qualify for free or discounted medications.

The List Of Cancers That Can Be Treated By Immunotherapy Keeps Growing

From Hope To Cures  |  From Our Network

The immunotherapy drug was beneficial regardless of whether a patient had been infected with HPV.

He won his own battle against cancer. Biden just picked him to lead a war

From Hope To Cures  |  From Our Network

The administration has asked Congress for $755 million for the effort; that's on top of $195 million going for moonshot activities this year.

Hansen: Methodist Hospital cancer center patients now greeted with a story — how one man beat an 'incurable' prognosis

From Hope To Cures  |  From Our Network

Every day at 11:30 a.m., Jon left his normal work duties in the lobby of the cancer center, took the elevator down to the basement and lay on a table, where radiation was fired at a spot roughly the size of a flattened orange inside his intestine.

PhRMA Statement on Support of DEA National Take Back Day

PhRMA  |  Press Release

PhRMA companies are leading the way in the search for new cures.

Access to Combination Therapies May Be Limited with Exchange Coverage

PhRMA  |  Blog Post

Despite the value these combination therapies provide to patients, access may be limited in health care exchange plans.

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

The platform can be viewed online here:

Dr. William "Bill" Chin, M.D.

PhRMA  |  Biography

Chin was at Eli Lilly and Company, where he had worked for the last decade, most recently as senior vice president for Discovery Research and Clinical Investigation.

#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

PhRMA  |  Blog Post

You can find information on events in other countries on the global Rare Disease Day website.

Winning the War Against Counterfeiters

PhRMA  |  Blog Post

Like in our Conversations series, views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.

Increasing Prescription Drug Cost Sharing for Medicaid Patients May Lead to Higher Total Medicaid Costs

Chartpack  |  From Our Network

For patients with very low incomes, even small increases in cost sharing can reduce access to needed care, which can lead to poor outcomes and increased program costs.

5 ways your insurer may prevent you from getting your medicine

PhRMA  |  Blog Post

These out-of-pocket costs can be real barriers to access because unlike a visit to the hospital where you’ll be treated no matter what, if you can’t pay for your medicine, you have to leave the pharmacy without it.

New Medicines Made Available through PDUFA

PhRMA  |  Graphic

The Prescription Drug User Fee Act (PDUFA) has helped bring more than 1,500 new safe and effective medications to patients.

Research In Your Backyard

PhRMA  |  From PhRMA

Click any state below to access the full report for that state.

Medicare Monday: 4 Things You May Not Know about Competition in Part D

PhRMA  |  Blog Post

Also be sure to share how Part D competition has benefitted you in the comments section below.

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits.

Partnership for Prescription Assistance Celebrates Five Year Anniversary and Launch of ‘PPA 2.0’

PhRMA  |  Press Release

More than 1,500 national, state and local partners, including the American Lung Association, American Cancer Society and National Urban League, are working with America’s pharmaceutical research and biotechnology companies to spread the word about the program.

Industry Economic Impact

PhRMA  |  From PhRMA

Research prepared for PhRMA by TEConomy Partners, LLC, analyzed state and national data across the large-scale biopharmaceutical sector supply chain and highlights how the discovery, development and delivery of innovative medicines translate into higher-wage jobs, increased tax revenue and greater economic output in our local communities.

Patient Spotlight: Matt Ellefson

PhRMA  |  Fact Sheet

“I’m Not Average” reminds us that every patient is unique, and has reason to remain hopeful for the future thanks in part to incredible innovations in medicine.

PhRMA Announces Major Commitment to Address the Opioid Crisis in America

PhRMA  |  Press Release

In addition to announcing the partnership with the Forum, PhRMA also released an expanded set of policy proposals to aggressively tackle the many drivers of the crisis.

PhRMA Statement on AARP Report

PhRMA  |  Press Release

“AARP’s report is misleading because nearly half of the drugs on its top 25 brand-name drug list were filled as generics in the first part of 2010, but AARP counts these drugs as if they were brand-name drugs.

You have reviewed the first 150 results out of 2146. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next